$COLL
COLLEGIUM PHARMACEUTICAL, INC

2023 Q4 Form 10-Q Financial Statement

#000155837023017983 Filed on November 07, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $149.7M $136.7M
YoY Change 15.53% 7.63%
Cost Of Revenue $55.12M $56.40M
YoY Change -30.96% -17.27%
Gross Profit $94.63M $80.31M
YoY Change 90.06% 36.49%
Gross Profit Margin 63.19% 58.75%
Selling, General & Admin $32.94M $35.30M
YoY Change -13.38% -8.01%
% of Gross Profit 34.81% 43.95%
Research & Development $0.00 $0.00
YoY Change
% of Gross Profit 0.0% 0.0%
Depreciation & Amortization $35.46M $37.10M
YoY Change -17.73% -2.47%
% of Gross Profit 37.48% 46.2%
Operating Expenses $32.94M $35.30M
YoY Change -13.38% -8.01%
Operating Profit $61.69M $45.01M
YoY Change 424.69% 119.93%
Interest Expense $19.28M $20.77M
YoY Change -6.29% 9.04%
% of Operating Profit 31.26% 46.14%
Other Income/Expense, Net
YoY Change
Pretax Income $46.71M $28.78M
YoY Change -699.54% 1909.99%
Income Tax $14.77M $8.149M
% Of Pretax Income 31.62% 28.31%
Net Earnings $31.94M $20.63M
YoY Change -543.67% 4415.1%
Net Earnings / Revenue 21.33% 15.09%
Basic Earnings Per Share $0.99 $0.61
Diluted Earnings Per Share $0.82 $0.53
COMMON SHARES
Basic Shares Outstanding 32.61M 34.73M
Diluted Shares Outstanding 41.28M 42.06M

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $315.3M $304.6M
YoY Change 81.52% 127.07%
Cash & Equivalents $238.9M $258.5M
Short-Term Investments $76.33M $46.03M
Other Short-Term Assets $93.00K $16.50M
YoY Change 63.16% 49.51%
Inventory $32.33M $34.13M
Prepaid Expenses $5.938M
Receivables $179.5M $181.9M
Other Receivables $0.00 $0.00
Total Short-Term Assets $537.6M $537.1M
YoY Change 28.0% 32.54%
LONG-TERM ASSETS
Property, Plant & Equipment $15.98M $16.65M
YoY Change -18.12% -15.7%
Goodwill $133.9M $133.9M
YoY Change 0.12% 2.89%
Intangibles $421.7M $456.2M
YoY Change -25.69% -25.18%
Long-Term Investments
YoY Change
Other Assets $825.0K $740.0K
YoY Change 725.0% 1198.25%
Total Long-Term Assets $605.7M $640.5M
YoY Change -19.68% -19.51%
TOTAL ASSETS
Total Short-Term Assets $537.6M $537.1M
Total Long-Term Assets $605.7M $640.5M
Total Assets $1.143B $1.178B
YoY Change -2.63% -1.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.692M $3.653M
YoY Change 148.77% -52.17%
Accrued Expenses $37.57M $31.65M
YoY Change 3.99% 38.84%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $183.3M $183.3M
YoY Change 12.82% 29.39%
Total Short-Term Liabilities $457.9M $464.6M
YoY Change 5.58% 12.09%
LONG-TERM LIABILITIES
Long-Term Debt $483.8M $527.7M
YoY Change -10.14% -9.31%
Other Long-Term Liabilities $6.124M $6.400M
YoY Change -13.89% -12.89%
Total Long-Term Liabilities $490.0M $534.1M
YoY Change -10.19% -9.36%
TOTAL LIABILITIES
Total Short-Term Liabilities $457.9M $464.6M
Total Long-Term Liabilities $490.0M $534.1M
Total Liabilities $947.9M $998.7M
YoY Change -3.21% -0.5%
SHAREHOLDERS EQUITY
Retained Earnings -$233.2M -$265.1M
YoY Change -17.12% -3.29%
Common Stock $38.00K $38.00K
YoY Change 2.7% 2.7%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $195.4M $178.9M
YoY Change
Total Liabilities & Shareholders Equity $1.143B $1.178B
YoY Change -2.63% -1.95%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income $31.94M $20.63M
YoY Change -543.67% 4415.1%
Depreciation, Depletion And Amortization $35.46M $37.10M
YoY Change -17.73% -2.47%
Cash From Operating Activities $73.34M $74.00M
YoY Change 10.57% 73.02%
INVESTING ACTIVITIES
Capital Expenditures $164.0K $100.0K
YoY Change -82.55% -188.5%
Acquisitions
YoY Change
Other Investing Activities -$24.93M -$3.700M
YoY Change
Cash From Investing Activities -$25.10M -$3.800M
YoY Change 2569.89% 3262.83%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -67.83M -95.50M
YoY Change 162.66% 205.58%
NET CHANGE
Cash From Operating Activities 73.34M 74.00M
Cash From Investing Activities -25.10M -3.800M
Cash From Financing Activities -67.83M -95.50M
Net Change In Cash -19.58M -25.30M
YoY Change -149.5% -321.85%
FREE CASH FLOW
Cash From Operating Activities $73.34M $74.00M
Capital Expenditures $164.0K $100.0K
Free Cash Flow $73.17M $73.90M
YoY Change 11.91% 72.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q3 coll Fair Value Liabilities Level1 To Level2 Transfers Amount1
FairValueLiabilitiesLevel1ToLevel2TransfersAmount1
0
CY2023Q3 coll Fair Value Liabilities Level1 To Level2 Transfers Amount1
FairValueLiabilitiesLevel1ToLevel2TransfersAmount1
0
CY2022Q3 coll Fair Value Assets Level2 To Level1 Transfers Amount1
FairValueAssetsLevel2ToLevel1TransfersAmount1
0
CY2023Q3 coll Fair Value Assets Level2 To Level1 Transfers Amount1
FairValueAssetsLevel2ToLevel1TransfersAmount1
0
CY2022Q3 coll Fair Value Liabilities Level2 To Level1 Transfers Amount1
FairValueLiabilitiesLevel2ToLevel1TransfersAmount1
0
CY2023Q3 coll Fair Value Liabilities Level2 To Level1 Transfers Amount1
FairValueLiabilitiesLevel2ToLevel1TransfersAmount1
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2022Q3 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2023#ProductMember
us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2023#ProductMember
CY2023Q3 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2023#ProductMember
CY2022Q3 us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
http://fasb.org/us-gaap/2023#ProductMember
us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
http://fasb.org/us-gaap/2023#ProductMember
CY2023Q3 us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
http://fasb.org/us-gaap/2023#ProductMember
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2023#ProductMember
us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
http://fasb.org/us-gaap/2023#ProductMember
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001267565
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37372
dei Entity Registrant Name
EntityRegistrantName
Collegium Pharmaceutical, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
VA
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
03-0416362
dei Entity Address Address Line1
EntityAddressAddressLine1
100 Technology Center Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
Stoughton
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02072
dei City Area Code
CityAreaCode
781
dei Local Phone Number
LocalPhoneNumber
713-3699
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
COLL
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
32610873
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
258532000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
173688000
CY2023Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
46033000
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
181851000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
183119000
CY2023Q3 us-gaap Inventory Net
InventoryNet
34125000
CY2022Q4 us-gaap Inventory Net
InventoryNet
46501000
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
16545000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
16681000
CY2023Q3 us-gaap Assets Current
AssetsCurrent
537086000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
419989000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16645000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19521000
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6243000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6861000
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
456222000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
567468000
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1047000
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
2547000
CY2023Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
25738000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
23950000
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
740000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
100000
CY2023Q3 us-gaap Goodwill
Goodwill
133857000
CY2022Q4 us-gaap Goodwill
Goodwill
133695000
CY2023Q3 us-gaap Assets
Assets
1177578000
CY2022Q4 us-gaap Assets
Assets
1174131000
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
3653000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3494000
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
31651000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
36129000
CY2023Q3 coll Accrued Rebates Returns And Discounts Current
AccruedRebatesReturnsAndDiscountsCurrent
245012000
CY2022Q4 coll Accrued Rebates Returns And Discounts Current
AccruedRebatesReturnsAndDiscountsCurrent
230491000
CY2023Q3 us-gaap Loans Payable Current
LoansPayableCurrent
183333000
CY2022Q4 us-gaap Loans Payable Current
LoansPayableCurrent
162500000
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
963000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1112000
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
464612000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
433726000
CY2023Q3 us-gaap Long Term Loans Payable
LongTermLoansPayable
265886000
CY2022Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
397578000
CY2023Q3 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
261823000
CY2022Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
140873000
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6384000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7112000
CY2023Q3 us-gaap Liabilities
Liabilities
998705000
CY2022Q4 us-gaap Liabilities
Liabilities
979289000
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
38000607
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33061932
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
37084759
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33848936
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
38000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
37000
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
545940000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
538073000
CY2023Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
4938675
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
3235823
CY2023Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
101924000
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
61924000
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-52000
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-265129000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-281344000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
178873000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
194842000
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1177578000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1174131000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
136709000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
127013000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
417022000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
334313000
CY2023Q3 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
20081000
CY2022Q3 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
30622000
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
74237000
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
80638000
CY2023Q3 us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
36317000
CY2022Q3 us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
37552000
us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
111246000
us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
93976000
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
56398000
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
68174000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
185483000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
174614000
CY2023Q3 us-gaap Gross Profit
GrossProfit
80311000
CY2022Q3 us-gaap Gross Profit
GrossProfit
58839000
us-gaap Gross Profit
GrossProfit
231539000
us-gaap Gross Profit
GrossProfit
159699000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3983000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
35298000
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
38372000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
126266000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
134154000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
35298000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
38372000
us-gaap Operating Expenses
OperatingExpenses
126266000
us-gaap Operating Expenses
OperatingExpenses
138137000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
45013000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
20467000
us-gaap Operating Income Loss
OperatingIncomeLoss
105273000
us-gaap Operating Income Loss
OperatingIncomeLoss
21562000
CY2023Q3 us-gaap Interest Expense
InterestExpense
20768000
CY2022Q3 us-gaap Interest Expense
InterestExpense
19046000
us-gaap Interest Expense
InterestExpense
64058000
us-gaap Interest Expense
InterestExpense
42638000
CY2023Q3 us-gaap Investment Income Net
InvestmentIncomeNet
4538000
CY2022Q3 us-gaap Investment Income Net
InvestmentIncomeNet
11000
us-gaap Investment Income Net
InvestmentIncomeNet
11312000
us-gaap Investment Income Net
InvestmentIncomeNet
20000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-23504000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
28783000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1432000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
29023000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-21056000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8149000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
975000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12808000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3253000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
20634000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
457000
us-gaap Net Income Loss
NetIncomeLoss
16215000
us-gaap Net Income Loss
NetIncomeLoss
-17803000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.61
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.47
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.52
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33744209
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34058802
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34226488
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33912832
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.53
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.46
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.52
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42058821
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34570319
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35149154
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33912832
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
20634000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
457000
us-gaap Net Income Loss
NetIncomeLoss
16215000
us-gaap Net Income Loss
NetIncomeLoss
-17803000
CY2023Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-14000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-52000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-14000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-52000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
20620000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
457000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
16163000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17803000
us-gaap Profit Loss
ProfitLoss
16215000
us-gaap Profit Loss
ProfitLoss
-17803000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
111246000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
93976000
us-gaap Depreciation
Depreciation
2547000
us-gaap Depreciation
Depreciation
1859000
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1047000
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
2547000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
259579000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
136673000
us-gaap Interest Paid Net
InterestPaidNet
57679000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1815000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-7313000
us-gaap Share Based Compensation
ShareBasedCompensation
20134000
us-gaap Share Based Compensation
ShareBasedCompensation
17204000
coll Operating Lease Payments Non Cash
OperatingLeasePaymentsNonCash
-258000
coll Operating Lease Payments Non Cash
OperatingLeasePaymentsNonCash
341000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
6672000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
5902000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-23504000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
667000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1268000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
34063000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-12376000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-30124000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-42000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-998000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
106000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3436000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-4479000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-24719000
coll Increase Decrease In Accrued Rebates Returns And Discounts
IncreaseDecreaseInAccruedRebatesReturnsAndDiscounts
14520000
coll Increase Decrease In Accrued Rebates Returns And Discounts
IncreaseDecreaseInAccruedRebatesReturnsAndDiscounts
-12040000
coll Increase Decrease In Operating Lease Asset And Liabilities
IncreaseDecreaseInOperatingLeaseAssetAndLiabilities
3000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
201411000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
57905000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
297000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
682000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
572069000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
51418000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
6000000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-45715000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-572751000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
460000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
337000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5401000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4948000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
8128000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3999000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
50000000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
6422000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
116667000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
50000000
coll Proceeds From Term Note Modification
ProceedsFromTermNoteModification
517682000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
6280000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
235220000
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
138638000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-72352000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
462546000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
83344000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-52300000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
176235000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
188973000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
259579000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
136673000
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
258532000
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
134126000
us-gaap Interest Paid Net
InterestPaidNet
35280000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
17293000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
10037000
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
53000
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
260000
us-gaap Revenue Practical Expedient Incremental Cost Of Obtaining Contract
RevenuePracticalExpedientIncrementalCostOfObtainingContract
true
coll Returns Policy Threshold Product Return Period
ReturnsPolicyThresholdProductReturnPeriod
P18M
coll Returns Policy Threshold Product Return Period Prior To Expiration
ReturnsPolicyThresholdProductReturnPeriodPriorToExpiration
P6M
coll Returns Policy Threshold Product Return Period After Expiration
ReturnsPolicyThresholdProductReturnPeriodAfterExpiration
P12M
coll Returns Policy Threshold Product Return Period
ReturnsPolicyThresholdProductReturnPeriod
P18M
us-gaap Net Income Loss
NetIncomeLoss
16215000
us-gaap Net Income Loss
NetIncomeLoss
-17803000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
136709000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
127013000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
417022000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
334313000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
20634000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
457000
CY2023Q3 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
1645000
CY2023Q3 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
22279000
CY2022Q3 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
457000
us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
16215000
us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
-17803000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33744209
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34058802
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34226488
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33912832
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42058821
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34570319
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35149154
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33912832
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.61
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.47
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.52
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.53
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.46
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.52
CY2022Q3 coll Fair Value Assets Level1 To Level2 Transfers Amount1
FairValueAssetsLevel1ToLevel2TransfersAmount1
0
CY2023Q3 coll Fair Value Assets Level1 To Level2 Transfers Amount1
FairValueAssetsLevel1ToLevel2TransfersAmount1
0
CY2023Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
150283000
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
172590000
CY2023Q3 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
458334000
CY2023Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
46033000
CY2023Q3 us-gaap Debt Securities Available For Sale Amortized Cost Current
DebtSecuritiesAvailableForSaleAmortizedCostCurrent
46085000
CY2023Q3 us-gaap Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax
DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax
-52000
CY2023Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
46033000
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
40116000
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
5917000
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
46033000
CY2022Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
0
coll Sale Of Marketable Securities
SaleOfMarketableSecurities
0
CY2023Q3 coll Sale Of Marketable Securities
SaleOfMarketableSecurities
0
CY2023Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
14393000
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
5600000
CY2023Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
9186000
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
24672000
CY2023Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
10546000
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
16229000
CY2023Q3 us-gaap Inventory Net
InventoryNet
34125000
CY2022Q4 us-gaap Inventory Net
InventoryNet
46501000
CY2023Q3 us-gaap Cost Direct Material
CostDirectMaterial
563000
us-gaap Cost Direct Material
CostDirectMaterial
1624000
CY2022Q4 us-gaap Goodwill
Goodwill
133695000
us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
162000
CY2023Q3 us-gaap Goodwill
Goodwill
133857000
CY2023Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
951170000
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
494948000
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
456222000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
956170000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
388702000
CY2022Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
6347000
CY2023Q3 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
1621000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
567468000
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
36317000
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
37552000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
111246000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
93976000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
34514000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
138062000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
138062000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
110370000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
7285000
CY2023Q3 coll Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
27929000
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
456222000
CY2023Q3 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
7483000
CY2022Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
13770000
CY2023Q3 coll Accrued Paybles For Inventory Current
AccruedPayblesForInventoryCurrent
6446000
CY2023Q3 coll Accrued Product Taxes And Fees Current
AccruedProductTaxesAndFeesCurrent
5128000
CY2022Q4 coll Accrued Product Taxes And Fees Current
AccruedProductTaxesAndFeesCurrent
4352000
CY2023Q3 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
4103000
CY2022Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
2130000
CY2023Q3 coll Accrued Incentive Compensation Current
AccruedIncentiveCompensationCurrent
1290000
CY2022Q4 coll Accrued Incentive Compensation Current
AccruedIncentiveCompensationCurrent
1507000
CY2023Q3 us-gaap Interest Payable Current
InterestPayableCurrent
1112000
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
1410000
CY2023Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1062000
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1957000
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
941000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1208000
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2465000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3448000
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
31651000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
36129000
CY2023Q3 coll Debt Instrument Margin Rate
DebtInstrumentMarginRate
0.075
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
194842000
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3848000
CY2023Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
169000
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1000
CY2023Q1 coll Stock Withheld For Employee Taxes Upon Vesting Of Restricted Stock Units And Performance Share Units Value
StockWithheldForEmployeeTaxesUponVestingOfRestrictedStockUnitsAndPerformanceShareUnitsValue
-7736000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6035000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-17426000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
179733000
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1251000
CY2023Q2 coll Stock Withheld For Employee Taxes Upon Vesting Of Restricted Stock Units And Performance Share Units Value
StockWithheldForEmployeeTaxesUponVestingOfRestrictedStockUnitsAndPerformanceShareUnitsValue
-220000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7072000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-38000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
13007000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
200805000
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
302000
CY2023Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
291000
CY2023Q3 coll Stock Withheld For Employee Taxes Upon Vesting Of Restricted Stock Units And Performance Share Units Value
StockWithheldForEmployeeTaxesUponVestingOfRestrictedStockUnitsAndPerformanceShareUnitsValue
-172000
CY2023Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
40000000
CY2023Q3 coll Adjustments To Additional Paid In Capital Forward Contract On Share Repurchase Agreement
AdjustmentsToAdditionalPaidInCapitalForwardContractOnShareRepurchaseAgreement
10000000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7027000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-14000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
20634000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
178873000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
202928000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3261000
CY2022Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
203000
CY2022Q1 coll Stock Withheld For Employee Taxes Upon Vesting Of Restricted Stock Units And Performance Share Units Value
StockWithheldForEmployeeTaxesUponVestingOfRestrictedStockUnitsAndPerformanceShareUnitsValue
-3382000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6135000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-13069000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
196076000
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1545000
CY2022Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1000
CY2022Q2 coll Stock Withheld For Employee Taxes Upon Vesting Of Restricted Stock Units And Performance Share Units Value
StockWithheldForEmployeeTaxesUponVestingOfRestrictedStockUnitsAndPerformanceShareUnitsValue
-511000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5692000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-5191000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
197612000
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
142000
CY2022Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
134000
CY2022Q3 coll Stock Withheld For Employee Taxes Upon Vesting Of Restricted Stock Units And Performance Share Units Value
StockWithheldForEmployeeTaxesUponVestingOfRestrictedStockUnitsAndPerformanceShareUnitsValue
-106000
CY2022Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
6422000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5377000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
457000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
197194000
CY2022Q3 us-gaap Incremental Common Shares Attributable To Accelerated Share Repurchase Agreements
IncrementalCommonSharesAttributableToAcceleratedShareRepurchaseAgreements
1702852
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7027000
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5377000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
20134000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
17204000
CY2023Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
50041000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y7M6D
CY2021 us-gaap Loss Contingency Claims Dismissed Number
LossContingencyClaimsDismissedNumber
13
CY2021Q4 us-gaap Loss Contingency Claims Settled Number
LossContingencyClaimsSettledNumber
27
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8149000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
975000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12808000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3253000
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.283
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.681
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.441
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.154
coll Effective Income Tax Rate Reconciliation Nondeductible Expense Debt Extinguishment Cost Amount
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDebtExtinguishmentCostAmount
21238000

Files In Submission

Name View Source Status
0001558370-23-017983-index-headers.html Edgar Link pending
0001558370-23-017983-index.html Edgar Link pending
0001558370-23-017983.txt Edgar Link pending
0001558370-23-017983-xbrl.zip Edgar Link pending
coll-20230930.xsd Edgar Link pending
coll-20230930x10q.htm Edgar Link pending
coll-20230930x10q001.jpg Edgar Link pending
coll-20230930xex31d1.htm Edgar Link pending
coll-20230930xex31d2.htm Edgar Link pending
coll-20230930xex32d1.htm Edgar Link pending
coll-20230930xex32d2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
coll-20230930_cal.xml Edgar Link unprocessable
coll-20230930_def.xml Edgar Link unprocessable
coll-20230930_lab.xml Edgar Link unprocessable
coll-20230930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
coll-20230930x10q_htm.xml Edgar Link completed
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending